Research library

1,766 reports · By date added

Bernstein: China’s innovative drugs gain global clinical validation: Kelun and Hansoh report strong data, while Innovent’s first-line lung cancer treatment remains under scrutiny

Bernstein believes the key change at ESMO 2026 was that several drugs developed in China produced efficacy data in global studies. Kelun-Biotech achieved a positive global phase III result, while Hansoh’s early data sustained the efficacy seen in China; Innovent’s IBI363 faces tests of efficacy durability and safety.

Goldman Sachs: Weichai Power: Data-center power generation’s share of profit rises to thirty percent, while gas-generator sets have yet to ramp up to take over

In the third quarter of 2026, data-center power generation offset weakness in traditional businesses and foreign-exchange pressure, driving Weichai Power’s EBIT to a record high. Goldman Sachs expects gas-generator sets to drive profit growth in 2027, but prioritizing diesel-engine capacity could push back some gas-generator deliveries.

Goldman Sachs: Goldman Sachs raises oil price forecasts: Supply disruption risks lift premium, but prices still expected to fall in 2027

Goldman Sachs raised its forecast for the average Brent crude price in 2027 from $80 to $88 per barrel and added an allowance for disruptions of 1 million barrels per day to its supply model. The bank believes the recent rise in oil prices has been driven mainly by a risk premium, while supply and demand adjustments have brought the global market back into balance.

Goldman Sachs: China’s insurers face investment and sales pressures in the third quarter as Goldman Sachs turns its attention to early-year sales and dividends

Falling stocks weighed on insurers’ profits, while growth in the value of new life insurance business also slowed markedly. Goldman Sachs expects its covered insurers to post an aggregate net loss in the fourth quarter if the market does not recover before year-end; property and casualty underwriting performed better than expected.